Literature DB >> 3048806

Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.

N J McHugh1, I E James, P J Maddison.   

Abstract

On investigating the immunoblotting profile of 65 systemic sclerosis patients, a 140 kD polypeptide was recognised by sera from 16, when immunoblotted against a nuclear-enriched K562 cell sonicate. All 16 sera contained anticentromere antibodies (ACA) detected by immunofluorescence (IF) and 15 of 16 also recognized a 19 kD polypeptide on immunoblotting. Two ACA positive sera failed to recognize the 140 kD polypeptide but one of these recognized the 19 kD polypeptide. The 140 kD polypeptide identified a group with more limited skin involvement (P less than 0.05) and all 16 had Raynaud's phenomenon. The sera from three of 100 systemic lupus erythematosus (SLE) patients also recognized both polypeptides. On investigating the isotype specificity, the 140 kD polypeptide was strongly detected by an IgM autoantibody and the 19 kD polypeptide by an IgG autoantibody.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048806      PMCID: PMC1541583     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Identification of human Sm and (U1) RNP antigens by immunoblotting.

Authors:  H H Guldner; H J Lakomek; F A Bautz
Journal:  J Immunol Methods       Date:  1983-11-11       Impact factor: 2.303

2.  Small ribonucleoproteins from eukaryotes: structures and roles in RNA biogenesis.

Authors:  J A Steitz; S L Wolin; J Rinke; I Pettersson; S M Mount; E A Lerner; M Hinterberger; E Gottlieb
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1983

3.  Serological markers in progressive systemic sclerosis: clinical correlations.

Authors:  L J Catoggio; R M Bernstein; C M Black; G R Hughes; P J Maddison
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

4.  Anticentromere antibodies in primary biliary cirrhosis.

Authors:  D Makinen; M Fritzler; P Davis; S Sherlock
Journal:  Arthritis Rheum       Date:  1983-07

5.  Frequency and clinical significance of anticentromere and anti Scl-70 antibodies in an English connective tissue disease population.

Authors:  L J Catoggio; R P Skinner; P J Maddison
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

6.  Anticentromere antibody in primary biliary cirrhosis.

Authors:  R M Bernstein; M E Callender; J M Neuberger; G R Hughes; R Williams
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

7.  Human anti-centromere sera recognise a 19.5 kD non-histone chromosomal protein from HeLa cells.

Authors:  H H Guldner; H J Lakomek; F A Bautz
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody.

Authors:  K M Pollard; E M Tan
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Human anticentromere antibodies: distribution, characterization of antigens, and effect on microtubule organization.

Authors:  J V Cox; E A Schenk; J B Olmsted
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

10.  Studies of antinuclear antibodies in rheumatoid arthritis.

Authors:  I Garcia-de la Torre; L Miranda-Mendez
Journal:  J Rheumatol       Date:  1982 Jul-Aug       Impact factor: 4.666

View more
  11 in total

1.  HLA class II restriction of autoantibody production in patients with systemic lupus erythematosus.

Authors:  H A Stephens; N J McHugh; P J Maddison; D A Isenberg; K I Welsh; G S Panayi
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis.

Authors:  N J McHugh; I E James; K Fairburn; P J Maddison
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

3.  Frequency and clinical associations of anti-chromo antibodies in connective tissue disease.

Authors:  E Soriano; J Whyte; N J McHugh
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

4.  Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.

Authors:  G R Harvey; S Butts; A L Rands; Y Patel; N J McHugh
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

5.  Epitope analysis of chromo antigen and clinical features in a subset of patients with anti-centromere antibodies.

Authors:  Y Muro; T Yamada; T Iwai; K Sugimoto
Journal:  Mol Biol Rep       Date:  1996       Impact factor: 2.316

6.  Anti-centromere antibodies (ACA) in systemic sclerosis patients and their relatives: a serological and HLA study.

Authors:  N J McHugh; J Whyte; C Artlett; D C Briggs; C O Stephens; N J Olsen; N G Gusseva; P J Maddison; C M Black; K Welsh
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

7.  Purification of a yeast centromere-binding protein that is able to distinguish single base-pair mutations in its recognition site.

Authors:  M J Cai; R W Davis
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

8.  Anticentromere-protein-B--DNA complex activities in anticentromere antibody-positive patients.

Authors:  Y Muro; Y Matsumoto; M Ohashi
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

9.  Characterisation of anticytoplasmic antibodies and their clinical associations.

Authors:  W H Koh; J Dunphy; J Whyte; J Dixey; N J McHugh
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

10.  Injection of anticentromere antibodies in interphase disrupts events required for chromosome movement at mitosis.

Authors:  R L Bernat; G G Borisy; N F Rothfield; W C Earnshaw
Journal:  J Cell Biol       Date:  1990-10       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.